Submitted by Anonymous on Fri, 07/24/2015 - 14:49
TARGET AUDIENCE
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of ovarian cancer (OC).
OVERVIEW OF ACTIVITY
Submitted by Anonymous on Fri, 07/24/2015 - 12:52
TARGET AUDIENCE
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of colorectal cancer (CRC).
OVERVIEW OF ACTIVITY
Submitted by Anonymous on Thu, 07/23/2015 - 14:18
TARGET AUDIENCE
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of non-small cell lung cancer (NSCLC).
OVERVIEW OF ACTIVITY
Submitted by web@researchtop... on Wed, 07/22/2015 - 15:00
TARGET AUDIENCE
This activity is intended for medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of breast and colon cancer.
Submitted by Anonymous on Tue, 07/21/2015 - 16:49
Submitted by Anonymous on Tue, 07/14/2015 - 11:52
TARGET AUDIENCE
This activity is intended for gynecologic and medical oncologists, gynecologists and other healthcare providers involved in the treatment of gynecologic cancers.
OVERVIEW OF ACTIVITY
Submitted by web@researchtop... on Mon, 07/13/2015 - 10:06
TARGET AUDIENCE
This activity is intended for medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of head and neck cancers and thyroid cancer.
Submitted by nenadkesic@gmail.com on Fri, 07/10/2015 - 07:21
Submitted by web@researchtop... on Mon, 07/06/2015 - 13:04
OVERVIEW OF ACTIVITY
In 2015 in the United States alone, it is estimated that 220,800 new cases of prostate cancer (PC) will occur. With an estimated 27,540 deaths in 2015, PC is the second-leading cause of cancer death in men. The disease has a tremendous global impact and has become the center of extensive ongoing clinical research. For this reason, the clinical management of PC is frequently in a state of evolution, necessitating rapid and consistent clinician access to emerging data sets relevant to the continuous delivery of quality cross-functional care.
Submitted by Anonymous on Fri, 06/26/2015 - 15:18
Submitted by web@researchtop... on Mon, 06/22/2015 - 09:29
OVERVIEW OF ACTIVITY
In 2015 in the United States alone it is estimated that 220,800 new cases of prostate cancer (PC) will occur. With an estimated 27,540 deaths in 2015, PC is the second-leading cause of cancer death in men. The disease has a tremendous global impact and has become the center of extensive ongoing clinical research. For this reason, the clinical management of PC is frequently in a state of evolution, necessitating rapid and consistent clinician access to emerging data sets relevant to the continuous delivery of quality cross-functional care.
Submitted by Anonymous on Thu, 06/18/2015 - 16:12
TARGET AUDIENCE
This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare professionals.
OVERVIEW OF ACTIVITY
Submitted by Anonymous on Thu, 06/18/2015 - 10:27
TARGET AUDIENCE
This activity has been designed to meet the educational needs of medical and radiation oncologists, urologists and other allied healthcare professionals.
OVERVIEW OF ACTIVITY
Submitted by Anonymous on Tue, 06/16/2015 - 10:38
Submitted by Anonymous on Tue, 06/09/2015 - 13:27
TARGET AUDIENCE
This educational activity has been designed to meet the educational needs of medical oncologists, hematology-oncology fellows, nurse practitioners and other allied cancer professionals involved in the treatment of lung cancer.
OVERVIEW OF ACTIVITY